Regorafenib improves survival after sorafenib in patients with recurrent HCC after liver transplantation. (March 2021) - Iavarone, M.; Invernizzi, F.; Ivanics, T.; Mazza, S.; Zavaglia, C.; Sanduzzi-Zamparelli, M.; Fraile-López, M.; Czauderna, C.; Costanzo, G. Di; Bhoori, S.; Pinter, M.; Manini, M.A.; et al.